British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

The health secretary wrote a 2014 book arguing that thimerosal caused brain damage, a claim his own agencies say is unfounded ...

A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...

Health experts were shocked to see that thimerosal, a preservative that has largely been phased out of U.S. vaccines, was on ...

Advisers to the Centers for Disease Control and Prevention recommended against flu shots containing the ingredient thimerosal ...

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.